In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

AIKEN C, NEF STIMULATES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL DNA-SYNTHESIS, JOURNAL OF VIROLOGY 69, 5048 (1995).

ALDOVINI A, MUTATIONS OF RNA AND PROTEIN SEQUENCES INVOLVED IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PACKAGING RESULT IN PRODUCTION OF NONINFECTIOUS VIRUS, JOURNAL OF VIROLOGY 64, 1920 (1990).

ANSARILARI M.A., ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE MUTANTS, VIROLOGY 211, 332 (1995).

BERKOWITZ R.D., 5′-REGIONS OF HIV-1 RNAS ARE NOT SUFFICIENT FOR ENCAPSIDATION - IMPLICATIONS FOR THE HIV-1 PACKAGING SIGNAL, VIROLOGY 212, 718 (1995).

BUCHSCHACHER G.L., HUMAN-IMMUNODEFICIENCY-VIRUS VECTORS FOR INDUCIBLE EXPRESSION OF FOREIGN GENES, JOURNAL OF VIROLOGY 66, 2731 (1992).

BUKRINSKY M.I., A NUCLEAR-LOCALIZATION SIGNAL WITHIN HIV-1 MATRIX PROTEIN THAT GOVERNS INFECTION OF NONDIVIDING CELLS, NATURE 365, 666 (1993).

BURNS J.C., VESICULAR STOMATITIS-VIRUS G GLYCOPROTEIN PSEUDOTYPED RETROVIRAL VECTORS - CONCENTRATION TO VERY HIGH-TITER AND EFFICIENT GENE-TRANSFER INTO MAMMALIAN AND NONMAMMALIAN CELLS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90, 8033 (1993).

BYRNES J.J., STRUCTURAL AND FUNCTIONAL-PROPERTIES OF DNA-POLYMERASE DELTA FROM RABBIT BONE-MARROW, MOLECULAR AND CELLULAR BIOCHEMISTRY 62, 13 (1984).

CARROLL R, A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-BASED RETROVIRAL VECTOR SYSTEM UTILIZING STABLE HIV-1 PACKAGING CELL-LINES, JOURNAL OF VIROLOGY 68, 6047 (1994).

CHARNEAU P, HIV-1 REVERSE TRANSCRIPTION - A TERMINATION STEP AT THE CENTER OF THE GENOME, JOURNAL OF MOLECULAR BIOLOGY 241, 651 (1994).

CHEN C, HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA, MOLECULAR AND CELLULAR BIOLOGY 7, 2745 (1987).

COHEN A, PURINE AND PYRIMIDINE METABOLISM IN HUMAN LYMPHOCYTES-T - REGULATION OF DEOXYRIBONUCLEOTIDE METABOLISM, JOURNAL OF BIOLOGICAL CHEMISTRY 258, 12334 (1983).

10.1126/science.270.5235.404

FINER M.H., KAT - A HIGH-EFFICIENCY RETROVIRAL TRANSDUCTION SYSTEM FOR PRIMARY HUMAN T-LYMPHOCYTES, BLOOD 83, 43 (1994).

GALLAY P, HIV-I INFECTION OF NONDIVIDING CELLS - C-TERMINAL TYROSINE PHOSPHORYLATION OF THE VIRAL MATRIX PROTEIN IS A KEY REGULATOR, CELL 80, 379 (1995).

GALLAY P, HIV NUCLEAR IMPORT IS GOVERNED BY THE PHOSPHOTYROSINE-MEDIATED BINDING OF MATRIX TO THE CORE DOMAIN OF INTEGRASE, CELL 83, 569 (1995).

GALLAY P, Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import, JOURNAL OF VIROLOGY 70, 1027 (1996).

GALLAY P unpublished data.

HEINZINGER N.K., THE VPR PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFLUENCES NUCLEAR-LOCALIZATION OF VIRAL NUCLEIC-ACIDS IN NONDIVIDING HOST-CELLS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 91, 7311 (1994).

HUBERMAN J.A., NEW VIEWS OF THE BIOCHEMISTRY OF EUKARYOTIC DNA-REPLICATION REVEALED BY APHIDICOLIN, AN UNUSUAL INHIBITOR OF DNA POLYMERASE-ALPHA, CELL 23, 647 (1981).

KASTAN M.B., A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY UTILIZING P53 AND GADD45 IS DEFECTIVE IN ATAXIA-TELANGIECTASIA, CELL 71, 587 (1992).

KAYE J.F., CIS-ACTING SEQUENCES INVOLVED IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA PACKAGING, JOURNAL OF VIROLOGY 69, 6588 (1995).

KIM H.J., A SHORT SEQUENCE UPSTREAM OF THE 5′ MAJOR SPLICE-SITE IS IMPORTANT FOR ENCAPSIDATION OF HIV-1 GENOMIC RNA, VIROLOGY 198, 336 (1994).

KNOWLES R.M., NEW ENGLAND JOURNAL OF MEDICINE 333, 823 (1995).

LANDAU N.R., PSEUDOTYPING WITH HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I BROADENS THE HUMAN-IMMUNODEFICIENCY-VIRUS HOST RANGE, JOURNAL OF VIROLOGY 65, 162 (1991).

LANDAU N.R., PACKAGING SYSTEM FOR RAPID PRODUCTION OF MURINE LEUKEMIA-VIRUS VECTORS WITH VARIABLE TROPISM, JOURNAL OF VIROLOGY 66, 5110 (1992).

LEAVITT A.D., Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection, JOURNAL OF VIROLOGY 70, 721 (1996).

LEIDEN J.M., GENE-THERAPY - PROMISE, PITFALLS, AND PROGNOSIS, NEW ENGLAND JOURNAL OF MEDICINE 333, 871 (1995).

LEVER A, IDENTIFICATION OF A SEQUENCE REQUIRED FOR EFFICIENT PACKAGING OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 RNA INTO VIRIONS, JOURNAL OF VIROLOGY 63, 4085 (1989).

LEWIS P, HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION OF CELLS ARRESTED IN THE CELL-CYCLE, EMBO JOURNAL 11, 3053 (1992).

LEWIS P.F., PASSAGE THROUGH MITOSIS IS REQUIRED FOR ONCORETROVIRUSES BUT NOT FOR THE HUMAN-IMMUNODEFICIENCY-VIRUS, JOURNAL OF VIROLOGY 68, 510 (1994).

LUBAN J, MUTATIONAL ANALYSIS OF CIS-ACTING PACKAGING SIGNALS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA, JOURNAL OF VIROLOGY 68, 3784 (1994).

10.1126/science.2305256

MCCORMICK P.J., BIOCHIM BIOPHYS ACTA 755, 36 (1983).

MEYERHANS A, RESTRICTION AND ENHANCEMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION BY MODULATION OF INTRACELLULAR DEOXYNUCLEOSIDE TRIPHOSPHATE POOLS, JOURNAL OF VIROLOGY 68, 535 (1994).

MILLER A.D., USE OF RETROVIRAL VECTORS FOR GENE-TRANSFER AND EXPRESSION, METHODS IN ENZYMOLOGY 217, 581 (1993).

MILLER D.G., GENE-TRANSFER BY RETROVIRUS VECTORS OCCURS ONLY IN CELLS THAT ARE ACTIVELY REPLICATING AT THE TIME OF INFECTION, MOLECULAR AND CELLULAR BIOLOGY 10, 4239 (1990).

MILLER M.D., THE HUMAN IMMUNODEFICIENCY VIRUS-1 NEF GENE-PRODUCT - A POSITIVE FACTOR FOR VIRAL-INFECTION AND REPLICATION IN PRIMARY LYMPHOCYTES AND MACROPHAGES, JOURNAL OF EXPERIMENTAL MEDICINE 179, 101 (1994).

MULLEN R.J., NEUN, A NEURONAL SPECIFIC NUCLEAR-PROTEIN IN VERTEBRATES, DEVELOPMENT 116, 201 (1992).

10.1126/science.8493530

NAIDINI L unpublished data.

NALDININ L unpublished data.

NOLAN G.P., FLUORESCENCE-ACTIVATED CELL ANALYSIS AND SORTING OF VIABLE MAMMALIAN-CELLS BASED ON BETA-D-GALACTOSIDASE ACTIVITY AFTER TRANSDUCTION OF ESCHERICHIA-COLI LACZ, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 85, 2603 (1988).

PAGE K.A., CONSTRUCTION AND USE OF A HUMAN-IMMUNODEFICIENCY-VIRUS VECTOR FOR ANALYSIS OF VIRUS INFECTIVITY, JOURNAL OF VIROLOGY 64, 5270 (1990).

PAROLIN C, ANALYSIS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VECTORS OF CIS-ACTING SEQUENCES THAT AFFECT GENE-TRANSFER INTO HUMAN-LYMPHOCYTES, JOURNAL OF VIROLOGY 68, 3888 (1994).

PEAR W.S., PRODUCTION OF HIGH-TITER HELPER-FREE RETROVIRUSES BY TRANSIENT TRANSFECTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90, 8392 (1993).

POZNANSKY M, GENE-TRANSFER INTO HUMAN-LYMPHOCYTES BY A DEFECTIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VECTOR, JOURNAL OF VIROLOGY 65, 532 (1991).

RATNER L, COMPLETE NUCLEOTIDE-SEQUENCE OF THE AIDS VIRUS, HTLV-III, NATURE 313, 277 (1985).

RICHARDSON J.H., HELPER VIRUS-FREE TRANSFER OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VECTORS, JOURNAL OF GENERAL VIROLOGY 76, 691 (1995).

RICHARDSON J.H., PACKAGING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA REQUIRES CIS-ACTING SEQUENCES OUTSIDE THE 5′ LEADER REGION, JOURNAL OF VIROLOGY 67, 3997 (1993).

ROE T.Y., INTEGRATION OF MURINE LEUKEMIA-VIRUS DNA DEPENDS ON MITOSIS, EMBO JOURNAL 12, 2099 (1993).

SCHARFMANN R, LONG-TERM INVIVO EXPRESSION OF RETROVIRUS-MEDIATED GENE-TRANSFER IN MOUSE FIBROBLAST IMPLANTS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 88, 4626 (1991).

SCHUITEMAKER H, PRODUCTIVE HIV-1 INFECTION OF MACROPHAGES RESTRICTED TO THE CELL FRACTION WITH PROLIFERATIVE CAPACITY, EMBO JOURNAL 13, 5929 (1994).

SHIMADA T, TARGETED AND HIGHLY EFFICIENT GENE-TRANSFER INTO CD4+ CELLS BY A RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS RETROVIRAL VECTOR, JOURNAL OF CLINICAL INVESTIGATION 88, 1043 (1991).

SONEOKA Y, A TRANSIENT 3-PLASMID EXPRESSION SYSTEM FOR THE PRODUCTION OF HIGH-TITER RETROVIRAL VECTORS, NUCLEIC ACIDS RESEARCH 23, 628 (1995).

SPECTOR D.H., HUMAN-IMMUNODEFICIENCY-VIRUS PSEUDOTYPES WITH EXPANDED CELLULAR AND SPECIES TROPISM, JOURNAL OF VIROLOGY 64, 2298 (1990).

SPINA C.A., THE IMPORTANCE OF NEF IN THE INDUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION FROM PRIMARY QUIESCENT CD4 LYMPHOCYTES, JOURNAL OF EXPERIMENTAL MEDICINE 179, 115 (1994).

TRONO D, HIV-1 GAG MUTANTS CAN DOMINANTLY INTERFERE WITH THE REPLICATION OF THE WILD-TYPE VIRUS, CELL 59, 113 (1989).

VERMA I.M., GENE-THERAPY - HOPES, HYPES, AND HURDLES, MOLECULAR MEDICINE 1, 2 (1994).

VICENZI E, AN INTEGRATION-DEFECTIVE U5 DELETION MUTANT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERTS BY ELIMINATING ADDITIONAL LONG TERMINAL REPEAT SEQUENCES, JOURNAL OF VIROLOGY 68, 7879 (1994).

VONSCHWEDLER U, THE NUCLEAR-LOCALIZATION SIGNAL OF THE MATRIX PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ALLOWS THE ESTABLISHMENT OF INFECTION IN MACROPHAGES AND QUIESCENT T-LYMPHOCYTES, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 91, 6992 (1994).

WEINBERG J.B., PRODUCTIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION OF NONPROLIFERATING HUMAN MONOCYTES, JOURNAL OF EXPERIMENTAL MEDICINE 174, 1477 (1991).

WILLIAMS R.S., HUMAN GENE-THERAPY - OF TORTOISES AND HARES, NATURE MEDICINE 1, 1137 (1995).

YEE J.K., A GENERAL-METHOD FOR THE GENERATION OF HIGH-TITER, PANTROPIC RETROVIRAL VECTORS - HIGHLY EFFICIENT INFECTION OF PRIMARY HEPATOCYTES, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 91, 9564 (1994).

ZACK J.A., HIV-1 ENTRY INTO QUIESCENT PRIMARY LYMPHOCYTES - MOLECULAR ANALYSIS REVEALS A LABILE, LATENT VIRAL STRUCTURE, CELL 61, 213 (1990).

ZACK J.A., INCOMPLETELY REVERSE-TRANSCRIBED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GENOMES IN QUIESCENT CELLS CAN FUNCTION AS INTERMEDIATES IN THE RETROVIRAL LIFE-CYCLE, JOURNAL OF VIROLOGY 66, 1717 (1992).